In COVID-19, it has been reported that CRP levels can be used for early identification of pneumonia [27] and the assessment of severe pulmonary infectious diseases [32], even though the exact effect remains unclear. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.